How are targeted therapies developed for cancer treatment?
Targeted therapies are designed to specifically attack cancer cells while sparing normal cells. The development of these therapies involves:
Identifying specific molecular targets that are crucial for the growth and survival of cancer cells. Developing drugs or biological agents, such as monoclonal antibodies, that specifically interact with these targets to inhibit their function. Conducting preclinical studies to assess the efficacy and safety of these agents in cell cultures and animal models. Performing clinical trials to evaluate the effectiveness and safety of the new therapies in humans, starting with small groups of patients and gradually expanding to larger populations.
